Vivo Capital VIII, LLC, 10% Owner at Nabriva Therapeutics plc (NBRV), bought 105,262 shares at $9.46 ($996K) on 2017-09-18, disclosed to the SEC on 2017-09-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.46 | 6,386 | $60K | 6.1% |
| 2 | $9.46 | 6,386 | $60K | 6.1% |
| 3 | $9.46 | 46,245 | $437K | 43.9% |
| 4 | $9.46 | 46,245 | $437K | 43.9% |
| Total | $9.46 avg | 105,262 | $996K | 100% |
| Filing → |
| CRNX | SELL | 2020-02-11 | $418K | — | Filing → |
| BPMX | SELL | 2019-06-27 | $669K | — | Filing → |
| BPMX | SELL | 2018-03-09 | $720K | — | Filing → |